Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells
- PMID: 11462053
- PMCID: PMC115016
- DOI: 10.1128/JVI.75.16.7769-7773.2001
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells
Abstract
The specific mechanisms by which antibodies neutralize flavivirus infectivity are not completely understood. To study these mechanisms in more detail, we analyzed the ability of a well-defined set of anti-dengue (DEN) virus E-glycoprotein-specific monoclonal antibodies (MAbs) to block virus adsorption to Vero cells. In contrast to previous studies, the binding sites of these MAbs were localized to one of three structural domains (I, II, and III) in the E glycoprotein. The results indicate that most MAbs that neutralize virus infectivity do so, at least in part, by the blocking of virus adsorption. However, MAbs specific for domain III were the strongest blockers of virus adsorption. These results extend our understanding of the structure-function relationships in the E glycoprotein of DEN virus and provide the first direct evidence that domain III encodes the primary flavivirus receptor-binding motif.
Figures



Similar articles
-
Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.Virology. 1998 Jul 5;246(2):317-28. doi: 10.1006/viro.1998.9200. Virology. 1998. PMID: 9657950
-
Epitope mapping of dengue 1 virus E glycoprotein using monoclonal antibodies.Arch Virol. 1995;140(7):1257-73. doi: 10.1007/BF01322751. Arch Virol. 1995. PMID: 7646356
-
[Recombinant envelope glycoprotein domain III of dengue virus inhibit virus infection].Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008 Jun;22(3):177-9. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008. PMID: 19031695 Chinese.
-
Survival of mice immunized with monoclonal antibodies against glycoprotein E of Japanese encephalitis virus before or after infection with Japanese encephalitis, West Nile, and Dengue viruses.Acta Virol. 2008;52(4):219-24. Acta Virol. 2008. PMID: 19143477
-
Analysis of the steps involved in Dengue virus entry into host cells.Virology. 1999 Apr 25;257(1):156-67. doi: 10.1006/viro.1999.9633. Virology. 1999. PMID: 10208929
Cited by
-
Structure-based identification of small-molecule inhibitors that target the DIII domain of the Dengue virus glycoprotein E pan-serotypically.PLoS One. 2024 Oct 25;19(10):e0311548. doi: 10.1371/journal.pone.0311548. eCollection 2024. PLoS One. 2024. PMID: 39453957 Free PMC article.
-
An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection.J Virol. 2013 Mar;87(6):3409-24. doi: 10.1128/JVI.02298-12. Epub 2013 Jan 9. J Virol. 2013. PMID: 23302884 Free PMC article.
-
Interaction and inhibition of dengue envelope glycoprotein with mammalian receptor DC-sign, an in-silico approach.PLoS One. 2013;8(3):e59211. doi: 10.1371/journal.pone.0059211. Epub 2013 Mar 18. PLoS One. 2013. PMID: 23527139 Free PMC article.
-
Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination.Virol J. 2016 Aug 18;13:142. doi: 10.1186/s12985-016-0598-z. Virol J. 2016. PMID: 27538960 Free PMC article.
-
Involvement of voltage-dependent anion channel (VDAC) in dengue infection.Sci Rep. 2016 Oct 25;6:35753. doi: 10.1038/srep35753. Sci Rep. 2016. PMID: 27779201 Free PMC article.
References
-
- Anderson R, King A D, Innis B L. Correlation of E protein binding with cell susceptibility to dengue 4 virus infection. J Gen Virol. 1992;73:2155–2159. - PubMed
-
- Chen Y, Maguire T, Hileman R E, Fromm J R, Esko J D, Linhardt R J, Marks R M. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med. 1997;3:866–871. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources